Colon-specific microparticles of piroxicam: Formulation and optimization using 32 factorial design

Journal of Dispersion Science and Technology

Volumn 32, Issue 10, 2011, Pages 1396-1403

  Sanka, Krishna ^a   Bandari, Suresh ^a   Jukanti, Raju ^a   Veerareddy, Prabhakar Reddy ^a  

^a ST PETER'S INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Colon; Eudragit s 100; Factorial design; Microparticles; Piroxicam

Indexed keywords

COLON; EUDRAGIT; FACTORIAL DESIGN; MICRO-PARTICLES; PIROXICAM;

DESIGN; DIFFERENTIAL SCANNING CALORIMETRY; DRUG INTERACTIONS; EMULSIFICATION; SCANNING ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION;

PYRIDINE;

EID: 80052975857     PISSN: 01932691     EISSN: 15322351     Source Type: Journal    
DOI: 10.1080/01932691.2010.513275     Document Type: Article

References (27)

1. Jain, A., Gupta, Y., and Jain, S.K. (2007) J. Pharm. Sci., 10: 86-128.
2. Krishnaiah, Y.S.R., Satyanarayana, V., Dinesh kuumar, B., and Karthikeyan, R.S. (2002) Eur. J. Pharm. Sci., 16: 185-192.
3. Akhgari, A., Garekani, H.A., Sadeghi, F., and Azimaie, M. (2005). Int. J. Pharm., 305: 22-30.
4. Krogars, K., Heinamaki, J., Marvola, M., Antikinen, O., and Yliruusi, J. (2000) Int. J. Pharm., 199: 187-194.
5. Sinha, V.R. and Kumari, R. (2001) Pharm. Res., 18: 557-564.
6. Mooter, G.V.D., Maris, B., Samyn, C., Augustjns, P., and Kinget, R. (1997) J. Pharm. Sci., 86: 1321-1327.
7. Mastiholimath, V.S., Dandagi, P.M., Jain, S.S., Gdad, A.P., and Kulkarni, A.R. (2007) Int. J. Pharm., 328: 49-56.
8. Ishibashi, T., Hatano, H., Yoshino, H., Mzobe, M., and Koyashi, M. (1998) Int. J. Pharm., 168: 31-40.
9. Ishibashi, T., Ikegami, K., Kubo, H., Kobayashi, M., Mizobe, M., and Yoshino, H. (1999) J. Control. Release, 59: 361-376.
10. Ishibashi, T., Hano, H., Kobayashi, M., Mizobe, M., and Yoshino, H. (1999) J. Control. Release, 57: 45-53.
11. Onishi, H., Osegi, T., and Machida, Y. (2008) Int. J. Pharm., 358: 296-302.
12. Zhao, X.L., Li, K.X., Zhao, X.F., Pang, D.H., and Chen, D.W. (2008) Chem. Pharm. Bull, 56: 963-968.
13. Hardy, F.H., Davis, S.S., Khosla, R., and Robertson, C.S. (1988) Int. J. Pharmacol., 48: 79-82.
14. Watts, P.J., Barro, L., Steed, K.P., Wilson, C.G., Spiller, R.C., Melia, C.D., and Davies, M.C. (1992) J. Pharmacol., 87: 215-221.
15. Hull, M.A., Gardner, S.H., and Hawcroft, G. (2003) Cancer. Treat. Rev., 29: 309-320.
16. Yamazaki, R., Kusunoki, N., Matsuzaki, T., Hashimoto, S., and Kawai, S. (2002) FEBS Lett., 531: 278-284.
17. Giardiello, F.M., Offerhaus, G.J., and Du Bois, R.N. (1995) Eur. J. Cancer, 31A: 1071-1076.
18. Lewis, A.J. and Furst, D.W. (1987) Non Steroidal Anti-Inflammatory Drugs: Mechanisms and Clinical Use; New York: Marcel Dekker.
19. Mueller, B.A., Rex, D.K., Figuerao, N., Greene, P., and Brater, D.C. (1992) Pharmacotherapy, 12: 193-197.
20. Earnest, D.L., Hixson, L.J., and Alberts, D.S. (1992) J. Cell. Biochem. Suppl., 16I: 156-166.
21. Jacoby, R.F., Marshall, D.J., Newton, M.A., Novakovic, K., Tutsch, K., Cole, C.E., Lubet, R.A., Kelloff, G.J., Verma, A., Moser, A.R., and Dove, W.F. (1996) Cancer Res., 56: 710-714.
22. Laprecht, A., Yamamoto, H., Takeuchi, H., and Kawashima, Y. (2004) Eur. J. Pharm. Biopharm., 58: 37-43.
23. Anande, N.M. and Jain, S.K. (2008) Int. J. Pharm., 359: 182-189.
24. Rajinikanth, P.S. and Mishra, B. (2008) Chem. Pharm. Bull., 56 (12): 1658-1664.
25. Rahman, Z., Kohli, K., Khar, R.K., Ali, M., Charoo, N.A., and Shamsher, A.A.A. (2006) AAPS PharmScitech. 7: Article No. 47.
26. Chourasia, M., Chourasia, M.K., Jain, N.K., Jain, A., Soni, V., and Gupta, J. (2006) AAPS Pharm. Scitech.7: Article No. 74.
27. Costa, P. and Sousa Lobo, J.M. (2001) Eur. J. Pharm. Sci., 13: 123-133.